330 related articles for article (PubMed ID: 34471463)
1. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.
Hu LF; Lan HR; Li XM; Jin KT
Oxid Med Cell Longev; 2021; 2021():2951697. PubMed ID: 34471463
[TBL] [Abstract][Full Text] [Related]
2. The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review.
Najafi M; Hooshangi Shayesteh MR; Mortezaee K; Farhood B; Haghi-Aminjan H
Life Sci; 2020 Jan; 241():117173. PubMed ID: 31843530
[TBL] [Abstract][Full Text] [Related]
3. The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review.
Moutabian H; Ghahramani-Asl R; Mortezazadeh T; Laripour R; Narmani A; Zamani H; Ataei G; Bagheri H; Farhood B; Sathyapalan T; Sahebkar A
Biofactors; 2022 May; 48(3):597-610. PubMed ID: 35080781
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review.
Zhang Q; Wu L
J Oncol; 2022; 2022():7277562. PubMed ID: 35237323
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity.
Singh M; Kadhim MM; Turki Jalil A; Oudah SK; Aminov Z; Alsaikhan F; Jawhar ZH; RamÃrez-Coronel AA; Farhood B
Cancer Cell Int; 2023 May; 23(1):88. PubMed ID: 37165384
[TBL] [Abstract][Full Text] [Related]
6. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.
Moutabian H; Majdaeen M; Ghahramani-Asl R; Yadollahi M; Gharepapagh E; Ataei G; Falahatpour Z; Bagheri H; Farhood B
Cancer Cell Int; 2022 Apr; 22(1):142. PubMed ID: 35366874
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Zhang DD
J Cell Mol Med; 2015 Oct; 19(10):2324-8. PubMed ID: 26177159
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity.
Zhang L; Zhu K; Zeng H; Zhang J; Pu Y; Wang Z; Zhang T; Wang B
Int J Nanomedicine; 2019; 14():6061-6071. PubMed ID: 31534336
[No Abstract] [Full Text] [Related]
10. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.
Sheibani M; Nezamoleslami S; Faghir-Ghanesefat H; Emami AH; Dehpour AR
Cancer Chemother Pharmacol; 2020 Mar; 85(3):563-571. PubMed ID: 31915967
[TBL] [Abstract][Full Text] [Related]
12. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
13. The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study.
Samadi M; Haghi-Aminjan H; Sattari M; Hooshangi Shayesteh MR; Bameri B; Armandeh M; Naddafi M; Eghbal MA; Abdollahi M
Life Sci; 2021 Jan; 265():118813. PubMed ID: 33275984
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity.
Pondugula SR; Harshan A; Ramesh S; Govindarajulu M; Almaghrabi M; Majrashi M; Abbott KL; Nadar R; Alturki M; Salamat JM; Smith F; Majeed M; Nagabhushanam K; Moore T; Ren J; Dhanasekaran M
Cardiovasc Toxicol; 2022 Jan; 22(1):67-77. PubMed ID: 34623620
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis.
Sin TK; Tam BT; Yung BY; Yip SP; Chan LW; Wong CS; Ying M; Rudd JA; Siu PM
J Physiol; 2015 Apr; 593(8):1887-99. PubMed ID: 25665036
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats.
Alanazi A; Fadda L; Alhusaini A; Ahmad R
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22492. PubMed ID: 32173980
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity.
Monahan DS; Flaherty E; Hameed A; Duffy GP
Biomed Pharmacother; 2021 Aug; 140():111702. PubMed ID: 34015579
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
Tian W; Yang L; Liu Y; He J; Yang L; Zhang Q; Liu F; Li J; Liu J; Sumi S; Shen Y; Qi Z
J Nutr Biochem; 2020 May; 79():108132. PubMed ID: 30857673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
